Molecular Determinants of Clinical Outcomes In a Real-World Diffuse Large B-cell Lymphoma PopulationWaleed Alduaij, David W. Scott, Brett Collinge et al.|Blood|2022Cited by 89
Relapse Timing Is Associated With Distinct Evolutionary Dynamics in Diffuse Large B-Cell LymphomaLaura K. Hilton, David W. Scott, Henry S. Ngu et al.|Journal of Clinical Oncology|2023Cited by 50
Impact of extramedullary multiple myeloma on outcomes with idecabtagene vicleucelSaurabh Zanwar, Doris K. Hansen, Gurbakhash Kaur et al.|Journal of Hematology & Oncology|2024Cited by 46
Single-cell profiling reveals a memory B cell-like subtype of follicular lymphoma with increased transformation riskXuehai Wang, Andrew P. Weng, Michael Nissen et al.|Nature Communications|2022Cited by 32